Product
Oral semaglutide
9 clinical trials
3 indications
Indication
Diabetes MellitusIndication
Type 2Indication
ObesityClinical trial
A Trial Investigating Semaglutide and SNAC Concentrations in Breastmilk Following Administration of Multiple Doses of Oral Semaglutide in Healthy, Lactating FemalesStatus: Completed, Estimated PCD: 2023-05-26
Clinical trial
A Multi-centre, Prospective, Non-interventional Single-arm Study Investigating Clinical Parameters Associated With the Use of Once-daily Oral Semaglutide in a Real-world Adult Population With Type 2 Diabetes in Saudi ArabiaStatus: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
A Multicentre, Prospective, Non-interventional Single-arm Study Investigating Clinical Parameters Associated With the Initiation of Once-daily Oral Semaglutide in a Real-world Adult Population With Type 2 Diabetes in IndiaStatus: Active (not recruiting), Estimated PCD: 2024-05-31
Clinical trial
A Multi-centre, Prospective, Non-interventional Single-arm Study Investigating Clinical Parameters Associated With the Use of Once-daily Oral Semaglutide in a Real-world Adult Population With Type 2 Diabetes in IsraelStatus: , Estimated PCD: 2024-11-03
Clinical trial
A Multi-centre, Prospective, Non-interventional Single-arm Study Investigating Clinical Parameters Associated With the Use of Once-daily Oral Semaglutide in a Real-world Adult Population With Type 2 Diabetes in ItalyStatus: Completed, Estimated PCD: 2023-11-03
Clinical trial
Efficacy and Safety of Once-daily Oral Semaglutide 25 mg and 50 mg Compared With 14 mg in Subjects With Type 2 DiabetesStatus: Completed, Estimated PCD: 2023-03-07
Clinical trial
Efficacy and Safety of Oral Semaglutide 50 mg Once Daily in Subjects With Overweight or Obesity (OASIS 1)Status: Completed, Estimated PCD: 2023-03-24
Clinical trial
China Multi-regional Clinical Trial: Efficacy and Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus Treated With MetforminStatus: Completed, Estimated PCD: 2021-10-27
Clinical trial
A Multi-centre, Prospective, Non-interventional Single-arm Study Investigating Clinical Parameters Associated With the Use of Once-daily Oral Semaglutide in a Real-world Adult Population With Type 2 Diabetes in the United KingdomStatus: Completed, Estimated PCD: 2023-08-31